BIOMAT Database Logo BIOMAT Database Logo

Ineffectiveness of AL721 in HIV disease. 1990

B S Peters, and J M Bennett, and D J Jeffries, and K Knox, and A Kocsis, and A J Pinching

UI MeSH Term Description Entries
D008297 Male Males
D010713 Phosphatidylcholines Derivatives of PHOSPHATIDIC ACIDS in which the phosphoric acid is bound in ester linkage to a CHOLINE moiety. Choline Phosphoglycerides,Choline Glycerophospholipids,Phosphatidyl Choline,Phosphatidyl Cholines,Phosphatidylcholine,Choline, Phosphatidyl,Cholines, Phosphatidyl,Glycerophospholipids, Choline,Phosphoglycerides, Choline
D010714 Phosphatidylethanolamines Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to an ethanolamine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and ethanolamine and 2 moles of fatty acids. Cephalin,Cephalins,Ethanolamine Phosphoglyceride,Ethanolamine Phosphoglycerides,Ethanolamineglycerophospholipids,Phosphoglyceride, Ethanolamine,Phosphoglycerides, Ethanolamine
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005989 Glycerides GLYCEROL esterified with FATTY ACIDS. Acylglycerol,Acylglycerols
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency

Related Publications

B S Peters, and J M Bennett, and D J Jeffries, and K Knox, and A Kocsis, and A J Pinching
Suppression of HIV antigenaemia by AL721.
May 1990, Lancet (London, England),
B S Peters, and J M Bennett, and D J Jeffries, and K Knox, and A Kocsis, and A J Pinching
AL721, a novel membrane fluidizer.
January 1987, Neuroscience and biobehavioral reviews,
B S Peters, and J M Bennett, and D J Jeffries, and K Knox, and A Kocsis, and A J Pinching
Leading HIV Vaccine Trial Stopped for Ineffectiveness.
March 2020, JAMA,
B S Peters, and J M Bennett, and D J Jeffries, and K Knox, and A Kocsis, and A J Pinching
31P-NMR assay of phosphatidylcholine and phosphatidylethanolamine in AL721.
January 1990, Journal of pharmaceutical and biomedical analysis,
B S Peters, and J M Bennett, and D J Jeffries, and K Knox, and A Kocsis, and A J Pinching
1H-NMR assay of phosphatidylcholine and phosphatidylethanolamine in AL721.
January 1990, Journal of pharmaceutical and biomedical analysis,
B S Peters, and J M Bennett, and D J Jeffries, and K Knox, and A Kocsis, and A J Pinching
[Ineffectiveness of cefotaxime in the treatment of Legionnaires' disease].
January 1983, Presse medicale (Paris, France : 1983),
B S Peters, and J M Bennett, and D J Jeffries, and K Knox, and A Kocsis, and A J Pinching
Is AL721 really a lipid fluidity modulating agent?
December 1988, The Journal of investigative dermatology,
B S Peters, and J M Bennett, and D J Jeffries, and K Knox, and A Kocsis, and A J Pinching
Ineffectiveness of infliximab therapy in severe infantile Crohn's disease.
February 2010, Journal of Crohn's & colitis,
B S Peters, and J M Bennett, and D J Jeffries, and K Knox, and A Kocsis, and A J Pinching
Ineffectiveness of vitamin A therapy in severe Crohn's disease.
January 1985, Acta chirurgica Scandinavica,
B S Peters, and J M Bennett, and D J Jeffries, and K Knox, and A Kocsis, and A J Pinching
NIH-sponsored clinical trials begin for antiviral drug AL721.
April 1988, The American journal of nursing,
Copied contents to your clipboard!